Spatial heterogeneity in the mechanisms contributing to acetylcholine-induced dilatation in the rabbit isolated ear

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1245-1253

  Berman, Rodney S ^a   Griffith, Tudor M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Acetylcholine; Calcium activated potassium channels; EDHF; Microangiography; Nitric oxide; Prostanoids; Rabbit ear

Indexed keywords

ACETYLCHOLINE; CHARYBDOTOXIN; HISTAMINE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; POTASSIUM CHANNEL BLOCKING AGENT; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; EAR; EAR ARTERY; MALE; MICROANGIOGRAPHY; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RABBIT; VASODILATATION; X RAY ANALYSIS;

ACETYLCHOLINE; ANIMALS; ARTERIES; CHARYBDOTOXIN; DEPRESSION, CHEMICAL; EAR; INDOMETHACIN; MALE; MYCOTOXINS; NG-NITROARGININE METHYL ESTER; RABBITS; SEROTONIN; VASODILATION;

EID: 0031853795     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701945     Document Type: Article

References (36)

1. BAUERSACHS, L., HECKER, M. & BUSSE, R. (1994). Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol., 113, 1548-1553.
2. BAUERSACHS, L., POPP, R., HECKER, M., SLAUER, E., FLEMING, I. & BUSSE, R. (1996). Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation, 94, 3341-3347.
3. BERMAN, R.S. & GRIFFITH, T.M. (1997). Differential actions of charybdotoxin on central and daughter branch arteries of the rabbit isolated ear. Br. J. Pharmacol., 120, 639-646.
4. CHAYTOR, A.T., EVANS, W.H. & GRIFFITH, T.M. (1998). Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J. Physiol., 508, 561-573.
5. COHEN, R.A., PLANE, R, NARBI, S., HUK, I., MALINSKI, T. & GARLAND, C.J. (1997). Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc. Natl. Acad. Sci. U.S.A., 94, 4193-4198.
6. DAINTY, I.A., McGRATH, L.C., SPEDDING, M. & TEMPLETON, A.G.B. (1990). The influence of the initial stretch and agonist-induced tone on the effect of basal and stimulated release of EDRF. Br. J. Pharmacol., 100, 767-773.
7. ATP and inward rectifier channels by charybdotoxin block in heart cells. Biophys. J., 70, A261.
8. 2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery. Br. J. Pharmacol. 120, 695-701.
9. EDWARDS, G., ZYGMUNT, P.M., HÖGESTÄTT, E.D. & WESTON, A.H. (1996). Effects of cytochrome P450 inihibitors on potassium currents and mechanical activity in rat portal vein. Br. J. Pharmacol., 119, 691-701.
10. + conductance. Br. J. Pharmacol., 115, 1221-1230.
11. GARLAND, C.J., PLANE, F., KEMP, B.K. & COCKS, T.M. (1995). Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.
12. + channels in rat renal arterioles. Am. J Physiol., 270, F69-F81.
13. GRIFFITH, T.M., EDWARDS, D.H., DAVIES, R.L., HARRISON, T.J. & EVANS, K.T. (1987). EDRF coordinates the behaviour of vascular resistance vessels. Nature, 329, 442-445.
14. GRIFFITH, T.M., EDWARDS, D.H., DAVIS, R.L., HARRISON, U. & EVANS, K.T. (1988). Endothelium-derived relaxing factor (EDRF) and resistance vessels in an intact vascular bed: a microangiographic study of the rabbit isolated ear. Br. J. Pharmacol., 93, 654-662.
15. V 1. 1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol., 45, 1227-1234.
16. GRYGLEWSKI, R.J., MONCADA, S. & PALMER, R.M.J. (1986). Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br. J. Pharmacol., 87, 685-694.
17. HECKER, M., BARA, A.T., BAUERSACHS, J. & BUSSE, R. (1994). Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-drived arachidonic acid metabolite in mammals. J. Physiol., 481, 407-414.
18. HWA, J.J., GHIBAUDI, L., WILLIAMS, P. & CHATERJEE, M. (1994). Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteic vascular bed. Am. J. Physiol., 266, H952-H958.
19. KNAUS, H., McMANUS, O.B., LEE, S.H., SCHMALHOFER, W.A., GARCIA-CALVO, M., HELMS, L.M.H., SANCHEZ, M., GIANGIACOMO, K., REUBEN, J.P., SMITH, A.B., III, KACZOROWSKI, G.J. & GARCIA, M.L. (1994). Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry, 33, 5819-5828.
20. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
21. + channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries. J. Physiol., 489, 723-734.
22. NELSON, M.T. & QUAYLE, J.M. (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol., 268, C799-C822.
23. PARSONS, S.J.W., HILL, A., WALDRON, G.J., PLANE, F. & GARLAND, C.J. (1994). The relative importance of nitric oxide and nitric oxide-independent mechanisms in acetylcholine-evoked dilatation of the rat mesenteric bed. Br. J. Pharmacol., 113, 1275-1280.
24. PETERSSON, L, ZYGMUNT, P.M. & HÖGESTÄTT, E.D. (1997). Characterization of the potassium channels involved in EDHF-mediated relaxation in cerebral arteries. Br. J. Pharmacol., 120, 1344-1350.
25. POPP, R., BAUERSACHS, L., HECKER, M., FLEMING, I. & BUSSE, R. (1996). A transferable, β-napthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J. Physiol., 497, 699-709.
26. RANDALL, M.D., ALEXANDER, S.P.H., BENNETT, T., BOYD, E.A., FRY, J.R., GARDINER, S.M., KEMP, P.A., MCCULLOCH, A.I. & KENDALL, D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun., 229, 114-120.
27. RANDALL, M.D., EDWARDS, D.H. & GRIFFITH, T.M. (1990). Activities of endothelin-1 in the vascular network of the rabbit ear: a microangiographic study. Br. J. Pharmacol., 101, 781-788.
28. SHIMOKAWA, H., YASUTAKE, H., FURI, K., OWADA, M.K., NAKAIKE, R., FUKUMOTO, Y., TAKAYANAGI, T., NAGAO, T., EGASHIRA, K., FURSHIMA, M. & TAKESHITA, A. (1996). The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J. Cardiovasc. Pharmacol., 28, 703-711.
29. + channel (Kv1.2) deactivation and inactivation kinetics. Eur. J. Pharmacol., 314, 357-364.
30. + channels in arterial smooth muscle. Science, 245, 177-180.
31. STORK, A.P. & COCKS, T.M. (1994). Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor. Br. J. Pharmacol., 113, 1099-1104.
32. TAYLOR, S.G. & WESTON, A.H. (1988). Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci., 9, 272-274.
33. WEKSLER, B.B., LEY, C.M. & JAFFE, E.A. (1978). Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A23187. J. Clin. Invest., 62, 923-930.
34. WIENER, H.L. & THALODY, G.P. (1993). Differential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta. J. Pharmacol. Exp. Ther., 267, 828-837.
35. XIA, L., LITTLE, T.L. & DULING, B.R. (1995). Cellular pathways of the conducted electrical response in arterioles of hamster cheek pouch in vitro. Am. J. Physiol., 269, H2031-H2038.
36. ZYGMUNT, P.M., EDWARDS, G., WESTON, A.H., DAVIS, S.C. & HOGESTATT, E.D. (1996). Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol., 118, 1147-1152.